Medicine Man Technologies, INC

Medicine Man Technologies, Inc. (Schwazze) entered a Restructuring Support Agreement to sell a majority of its assets to a Vireo Growth Inc. affiliate and liquidate remaining operations, following debt defaults.

Medicine Man Technologies, Inc. has appointed Philippe Faraut, an executive with over 25 years of experience, as its Interim Chief Financial Officer, effective July 14, 2025.

Medicine Man Technologies, Inc. announces the termination of employment of its Chief Policy and Regulatory Affairs Officer, Daniel Pabon, effective April 30, 2025, with a separation agreement in place.

Medicine Man Technologies, Inc. has appointed Bob Finley of FLG Partners as its Interim Chief Financial Officer, effective April 21, 2025, while the company continues its search for a permanent CFO.

Medicine Man Technologies' subsidiary, PBS Holdco, defaulted on a loan agreement, leading to the lender seizing $1.5 million from the subsidiary's bank accounts.

Medicine Man Technologies has reported a default on its debt obligations due to delayed financial filings and announced the appointment of Forrest Hoffmaster as CEO, while also planning a restatement of past financial results.

Medicine Man Technologies, Inc., doing business as Schwazze, provides a detailed overview of its capital structure, regulatory compliance, and business operations in its recent 10-K filing.

Medicine Man Technologies' Chief Legal Officer, Christine Jones, has resigned, resulting in the forfeiture of all her unexercised employee stock options.

Daniel Pabon, Chief Policy Officer of Medicine Man Technologies, Inc., was granted stock options to purchase 88,214 shares of Class A Common Stock on August 28, 2024.

Christine Jones, Chief Legal Officer of Medicine Man Technologies, acquired 91,742 stock options on August 28, 2024.

Forrest Hoffmaster, CFO of Medicine Man Technologies, acquired stock options on August 28, 2024.

Director Kathy Vrabeck received 67,308 shares of Medicine Man Technologies (SHWZ) common stock as compensation for board service.

Director Brad Stewart reports acquisition and disposal of Medicine Man Technologies (SHWZ) common stock on June 28, 2024, according to a Form 4 filing.

Schwazze Inc. (d/b/a Schwazze) will hold its annual meeting on June 20, 2024, seeking stockholder approval on director elections, auditor ratification, and amendments to its equity incentive plan and articles of incorporation.

Medicine Man Technologies, Inc., doing business as Schwazze, is holding its 2024 Annual Meeting of Stockholders to vote on key proposals including the election of directors, ratification of the independent accountant, amendments to the equity incentive plan and articles of incorporation, and executive compensation.